UK markets closed

Taysha Gene Therapies, Inc. (TSHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3900+0.0900 (+3.91%)
At close: 04:00PM EDT
2.3900 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,451
15,451
2,502
0
0
Operating expenses
Research development
56,778
56,778
91,169
131,943
31,893
Selling general and administrative
30,047
30,047
37,360
41,324
11,109
Total operating expenses
86,825
86,825
128,529
173,267
43,002
Operating income or loss
-71,374
-71,374
-126,027
-173,267
-43,002
Interest expense
4,998
4,998
3,798
1,428
28
Total other income/expenses net
-38,766
-38,766
-36,438
-
-17,030
Income before tax
-111,566
-111,566
-166,014
-174,523
-60,011
Income from continuing operations
-111,566
-111,566
-166,014
-174,523
-60,011
Net income
-111,566
-111,566
-166,014
-174,523
-60,011
Net income available to common shareholders
-111,566
-111,566
-166,014
-174,523
-60,011
Basic EPS
-2.87
-
-3.78
-4.64
-3.40
Diluted EPS
-2.87
-
-3.78
-4.64
-3.40
Basic average shares
77,604
-
43,952
37,651
17,666
Diluted average shares
77,604
-
43,952
37,651
17,666